ELV Q2 2023 Earnings — Elevance Health Inc. Revenue & Financial Results | Market Cap Arena

ELVElevance Health Inc.

$64B

Q2 2023 Earnings

Healthcare Medical - Healthcare Plans

Income Statement

Revenue

$43.7B+13.0% YoY

Gross Profit

$12.1B27.6% margin

Operating Income

$2.7B6.2% margin

Net Income

$1.9B4.2% margin

EPS (Diluted)

$7.79

QoQ Revenue Growth

+3.6%

Cash Flow

Operating Cash Flow

$1.9B

Free Cash Flow

$1.6B

Stock-Based Comp.

$78M

Balance Sheet

Total Assets

$109.2B

Total Liabilities

$70.9B

Stockholders' Equity

$38.2B

Cash & Equivalents

$10.0B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$43.7B	$38.6B	+13.0%
Gross Profit	$12.1B	$9.8B	+22.7%
Operating Income	$2.7B	$2.3B	+16.0%
Net Income	$1.9B	$1.6B	+13.2%

Revenue Segments

Health Benefits Segment

$38.0B61%

Carelon Services Segment

$23.8B38%

Other Segment

$326M1%